A Prospective, Observational Study of Factors Affecting Blood Pressure and Blood Lipids After Treatment With Amosartan Q Tablet in Hypertension Patients With Dyslipidemia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 5,400
- 试验地点
- 1
- 主要终点
- percentage(%) of patients who achieved target LDL-C
研究概览
简要总结
This study was to evaluate the therapeutic effect and safety of amosartan Q tablet administration in adult patients with hypertension and dyslipidemia.
During the routine medical visit, Amosartan Q tablets were administered to patients in need of blood pressure/LDL-C control according to the investigator's judgment. In this study, effectiveness and safety information of treatment of Amosartan Q tablets was followed for 6 months (up to 12 months), and observation of the target patients was terminated after collecting relevant data.
As this study was a non-interventional observational study, all patients received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.
详细描述
This study was a multicenter, prospective, non-interventional, observational study of factors affecting blood pressure and blood lipids after treatment with Amosartan Q tablet in hypertension patients with dyslipidemia.
Data was collected from patients receiving routine treatment at hospitals in South Korea. Each patient visited the institution according to the protocol that designed the follow-up visits for six months to examine the effectiveness and safety of Amosartan Q tablet.
This study approved by the institutions' IRBs and was conducted in compliance with clinical research ethics regulations.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with hypertension and dyslipidemia
- •Those who have already decided to administer Amosartan Q tablet under the medical judgment of the researcher
- •Those who voluntarily decided to participate in this study and consented in writing to the consent form
排除标准
- •Patients for whom use of Amosartan Q tablet is prohibited
研究组 & 干预措施
single arm, single group(No interventional)
Observational
干预措施: Amosartan Q tablet (Drug)
结局指标
主要结局
percentage(%) of patients who achieved target LDL-C
时间窗: 6 months
percentage(%) of patients who achieved target blood pressure
时间窗: 6 months
次要结局
未报告次要终点